MLICM
CBMG

Metropolitan Life Insurance Company (MetLife)’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CBMG Stock Details CBMG Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
2020
Q3 		$81.4K Buy
2020
Q2 		– Sell
2020
Q1 		$69.4K Buy
2019
Q1 		– Sell
2018
Q4 		$80.8K Buy
2016
Q2 		– Sell
2016
Q1 		$161K Buy
2015
Q4 		$171K Sell
2015
Q3 		$151K Buy
2015
Q2 		$332K Buy